AF
BNTC icon

Allworth Financial’s Benitec Biopharma BNTC Stock Holding History

Allworth Financial’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$509 Sell
38
-149
-80% -$1.77K ﹤0.01% 4849
2026
Q1 		$1.99K Buy
+187
New +$2.17K ﹤0.01% 4354

Other funds holding BNTC

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

Allworth Financial's BNTC Position: Q2 2026 in Review

Allworth Financial reduced its Benitec Biopharma (BNTC) stake by 80% in Q2 2026, selling an estimated $1.77K and leaving 38 shares worth $509. The position accounts for ﹤0.01% of the portfolio, ranked #4849.

Allworth Financial first reported a position in BNTC in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.99K in Q1 2026. 87 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • Allworth Financial held 38 shares of Benitec Biopharma worth $509 as of Q2 2026.
  • Allworth Financial sold 149 Benitec Biopharma shares in Q2 2026, an estimated $1.77K.
  • Benitec Biopharma made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4849 holding.
  • Allworth Financial first reported a position in Benitec Biopharma in Q1 2026 and has held it in 2 quarters since.
  • Allworth Financial's Benitec Biopharma position peaked at $1.99K in Q1 2026.
  • 87 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.